Top Markets
Coin of the day
AIkido Pharma Inc. AIkido Pharma Inc.

AIkido Pharma Inc.

AIKI
Classificação em ações #30001
AIkido Pharma Inc., established in 1967 and headquartered in New York, New... AIkido Pharma Inc., established in 1967 and headquartered in New York, New York, is a biotechnology company primarily engaged in pioneering small-molecule anti-cancer treatments. The firm, which operated as Spherix Incorporated until its rebranding in March 2021, possesses a robust therapeutic pipeline addressing various malignancies, including prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. Key drug candidates in its development portfolio include DHA-dFdC, targeting pancreatic cancer, and KPC34, a small molecule designed for the treatment of both AML and acute lymphoblastic leukemia. Furthermore, AIkido Pharma Inc. is advancing an antiviral platform engineered to hinder the proliferation of numerous viruses, such as the influenza virus, Ebolavirus, Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. The company holds strategic license agreements with several academic and research institutions, including the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences.
Preço da ação
$3.56
Última sincronização: 2022-12-21
Valor de mercado
$18.70M
Variação (1 dia)
0.28%
Variação (1 ano)
0.00%
País
US
Negociar AIkido Pharma Inc. (AIKI)

Categoria

Histórico de preços das ações de AIkido Pharma Inc. (AIKI)
Preço de fecho mais alto: $3.56 em 2022-12-01

Preço de fecho mais baixo: $11.43 em 2020-03-01
Histórico de preços das ações da AIkido Pharma Inc. de 2020 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2022 -68.17%
2021 0.42%
2020 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$730.65 5.32%
CH
$1.07K -5.58%
KR